Target intelligence / Profile preview

Kelch-like ECH-associated protein 1–Phosphoglycerate mutase family member 5 complex (Keap1–PGAM5 complex)

Target
Keap1–PGAM5 complex
Molecular classification
Protein complex, E3 ubiquitin ligase adapter, Mitochondrial protein phosphatase
01

Overview

The Keap1–PGAM5 complex is a regulatory assembly formed by the interaction between Kelch-like ECH-associated protein 1 (Keap1) and the mitochondrial phosphatase Phosphoglycerate mutase family member 5 (PGAM5). Keap1 is primarily known as the substrate adapter for the Cullin 3-based E3 ubiquitin ligase that targets the antioxidant transcription factor Nrf2 for degradation. PGAM5, localized to the outer mitochondrial membrane, contains a conserved NXESGE motif that binds to the Kelch domain of Keap1, effectively anchoring Keap1 to the mitochondria and influencing its ability to regulate Nrf2. This complex serves as a critical link between mitochondrial status and the cellular oxidative stress response, playing significant roles in mitophagy and necroptosis. In disease contexts, the Keap1–PGAM5 axis is often dysregulated; for instance, in certain cancers, it can contribute to metabolic reprogramming and survival, while in neurodegenerative conditions like Parkinson's disease, it affects mitochondrial integrity. Therapeutic interest focuses on small molecules that can disrupt or stabilize this interaction to fine-tune cellular resilience against oxidative damage and mitochondrial dysfunction.

Other names
Keap1-PGAM5 interactionKeap1-PGAM5 axisKEAP1-PGAM5 protein complex
02

Mechanism of action

Inhibition of the protein-protein interaction between Keap1 and PGAM5 to prevent mitochondrial sequestration of Keap1, thereby modulating Nrf2-mediated antioxidant responses and mitochondrial quality control.

03

Biological functions

Oxidative stress responseMitophagyNecroptosisMitochondrial dynamicsNrf2 signaling regulationApoptosis
04

Disease associations

CancerNeurodegenerative diseaseIschemia-reperfusion injuryInflammationParkinson's disease
05

Safety considerations

Potential for constitutive Nrf2 activation promoting tumor growth and chemoresistanceDisruption of normal mitochondrial homeostasisOff-target effects on other Keap1-binding proteins
06

Interacting drugs

Small molecule Keap1-PGAM5 interaction inhibitors (experimental)
07

Biomarkers

Nrf2 protein levelsReactive oxygen species (ROS) levelsPGAM5 expression levelsLC3-II (mitophagy marker)Heme oxygenase 1 (HO-1) expression

Beyond the preview

Go deeper on Kelch-like ECH-associated protein 1–Phosphoglycerate mutase family member 5 complex (Keap1–PGAM5 complex).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kelch-like ECH-associated protein 1–Phosphoglycerate mutase family member 5 complex (Keap1–PGAM5 complex).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call